{
  "Variants Include": [
    {
      "Gene": "LRRK2",
      "variants": [
        {
          "HGVS": "(wild-type transcript):c.I2020T",
          "cDNA Change": {
            "transcript": "(wild-type transcript)",
            "ref": "G",
            "alt": "T",
            "position": "2020"
          },
          "Protein Change": {
            "ref": "G",
            "alt": "T",
            "position": "2020"
          },
          "Description in input context": "I2020T mutation."
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Autosomal dominant familial Parkinson's disease (PD)",
    "MONDO": "MONDO:99768"
  },
  "Experiment Method": [
    {
      "Assay Method": "Cytotoxicity assay",
      "Material used": {
        "Material Source": "HEK293 cells",
        "Material Name": "Cell culture",
        "Description": "Hydrogen peroxide treatment at 37Â°C for 24 hours."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "(wild-type transcript):c.I2020T",
          "Conclusion": "Impaired",
          "Molecular Effect": "Insufficient protease resistance",
          "Result Description": "Apoptosis was significantly reduced in the presence of wild-type LRRK2 protein."
        },
        {
          "Variant": "(wild-type transcript):c.I2020T",
          "Conclusion": "Rescued",
          "Molecular Effect": "Restoration with proteolysis inhibitors",
          "Result Description": "Proteolysis inhibitors (e.g., Bafiloxin) effectively restored apoptosis resistance."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Testing was performed in triplicate for each condition to ensure reproducibility."
      },
      "Technical replicates": {
        "Technical replicates": "N/A",
        "Description": "Not specified in the literature."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type LRRK2 protein treated with proteolysis inhibitors showed no significant reduction in apoptosis."
      },
      "Basic negative control": {
        "Basic negative control": "N/A",
        "Description": "Not applicable as no controls were mentioned for this assay."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N/A",
        "Counts": "0"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N/A",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "N.D.",
        "Source": "Literature or custom determination"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "N.D.",
        "Source": "Literature or custom determination"
      },
      "Approved assay": {
        "Approved assay": "Yes",
        "Approval source": "Commonly used in PD studies"
      }
    }
  ]
}